It is reasonable to anticipate that, if retatrutide receives approval, similar principles will apply
Weight loss from GLP-1 medications can be rapid (typically 5-15% of body weight over several months), and MS patients must ensure adequate protein and micronutrient intake to support neurological function, immune regulation, and muscle preservation
This is a precaution to protect both your safety and recovery, and you may be able to donate once your condition improves
It acts the same way as GLP-1 (a hormone produced in the gut)
Pharmacologically mediated marked initial maternal body weight loss and reductions in body weight gain and food consumption coincided with an increase in early pregnancy losses and led to delivery of slightly smaller offspring at 0.075 mg/kg twice weekly (2X human exposure)
If you miss your morning dose, simply skip it entirely for that day